Abstract: The disclosure provides a method of treating a substance use disorder in a subject, comprising administering to the subject a therapeutically effective amount of a composition comprising R(?)-ketamine or a pharmaceutically acceptable salt thereof, wherein the composition is substantially free of S(+)-ketamine or a pharmaceutically acceptable salt thereof.
Type:
Grant
Filed:
May 3, 2019
Date of Patent:
August 30, 2022
Assignee:
Perception Neuroscience, Inc.
Inventors:
Jeffrey M. Witkin, Jonathan Sporn, Jay D. Kranzler